Categories
- PROTAC Linker
- Protein Control Ligand
- Pathway Inhibitors
- Function Modulators
- Activators
- G Protein-Coupled Receptor Ligands
- Nuclear Receptor Ligands
- GDNF Receptors
- TNF Receptors
- Transcription Factors
- Chemokines
- Cytokine Receptors
- Biomarkers and Buffer Solutions
- Molecular Probes
- Stem Cell Research
- Alzheimer's Disease
- Apoptosis
- Cancer Research
- Epigenetics
- Metabolites
- PET/SPECT Imaging Precursors
- Customized Screening Library
- Ultra Pure Pharmacological Standard
- Tissue Microarray (TMA)
- Proteins and Antibodies
- Primary Cells
- ELISA KIT
- Natural Products
- Lab Equipments
- Humanized Mice for PDX Platform
- Rare Chemicals
- Custom Synthesis
- Antibacterial
- Antifungal
- Antioxidant
- Antiviral
- Molecular Glues
- SARS-CoV
Quantity Discount Table - Order More To Get More Price Discount
| Quantity | mg | Unit Price ($/mg or $/Unit) | Final Price |
|---|---|---|---|
| 1 | 5 | $374.00 | Total: $1,870.00 |
| 1 | 10 | $316.80 | Total: $3,168.00 |
| 1 | 25 | $268.40 | Total: $6,710.00 |
| 1 | 50 | $228.80 | Total: $11,440.00 |
| 1 | 100 | $198.00 | Total: $19,800.01 |
Overview
Roxifiban acetate?DMP 754 acetate? is a potent GP IIb IIIa antagonist that exhibits antiplatelet aggregation activity via immune mediation and can be used in the study of human thrombocytopenia.
Chemical Properties
| Molecular Formula | C23H33N5O8 |
| Molecular Weight | 507.54 |
| CAS Numbers | 176022-59-6 |
| Solubility | DMSO |
| Purity | 98% by HPLC |
| SMILES Code | C(C)(O)=O.C(C(NC[C@H](NC(OCCCC)=O)C(OC)=O)=O)[C@H]1CC(=NO1)C2=CC=C(C(=N)N)C=C2 |
Storage and Handling
0C Short Term, -20C Long Term
References
Murphy J,et al.The use of roxifiban [DMP754], a novel oral platelet glycoprotein IIbIIIa receptor inhibitor, in patients with stable coronary artery disease. Am J Cardiovasc Drugs. 2003;3[2] 101-12.